Search research articles
Contact Us
Filters
Showing results (101-110 of 361) with videos related to
Page
of 37
Sort By:
The Medical Clinics of North America
|
February 12, 2004
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease
James R Sowers, Edward D Frohlich
Journal of the American College of Cardiology
|
December 1, 1989
The evolution of antihypertensive therapy: an overview of four decades of experience
G L Bakris, E D Frohlich
The American Journal of Medicine
|
September 26, 1983
Cardiovascular adjustment to antiadrenergic agents
B L Pegram, E D Frohlich
The American Journal of Cardiology
|
October 22, 1979
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?
E D Frohlich, R C Tarazi
American Journal of Physiology. Heart and Circulatory Physiology
|
July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation
Marc A Pfeffer, Edward D Frohlich
Chest
|
May 1, 1990
One-year longitudinal study of a no-smoking policy in a medical institution
L G Hudzinski, E D Frohlich
Circulation
|
January 1, 1987
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
R C Tarazi, E D Frohlich
The American Journal of Cardiology
|
June 15, 1988
Cardiac involvement in hypertension
D J DiPette, E D Frohlich
Clinical Science and Molecular Medicine. Supplement
|
June 1, 1975
Adrenergic mechanisms in human hypertension and in spontaneously hypertensive rats
E D Frohlich, M A Pfeffer
Archives of Internal Medicine
|
June 1, 1979
High blood pressure. A side effect of drugs, poisons, and food
F H Messerli, E D Frohlich
Page
of 37
Search research articles
Search
Showing results (101-110 of 361) with videos related to
Sort By:
Page
of 37
The Medical Clinics of North America
|
February 12, 2004
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease
James R Sowers, Edward D Frohlich
Journal of the American College of Cardiology
|
December 1, 1989
The evolution of antihypertensive therapy: an overview of four decades of experience
G L Bakris, E D Frohlich
The American Journal of Medicine
|
September 26, 1983
Cardiovascular adjustment to antiadrenergic agents
B L Pegram, E D Frohlich
The American Journal of Cardiology
|
October 22, 1979
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?
E D Frohlich, R C Tarazi
American Journal of Physiology. Heart and Circulatory Physiology
|
July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation
Marc A Pfeffer, Edward D Frohlich
Chest
|
May 1, 1990
One-year longitudinal study of a no-smoking policy in a medical institution
L G Hudzinski, E D Frohlich
Circulation
|
January 1, 1987
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
R C Tarazi, E D Frohlich
The American Journal of Cardiology
|
June 15, 1988
Cardiac involvement in hypertension
D J DiPette, E D Frohlich
Clinical Science and Molecular Medicine. Supplement
|
June 1, 1975
Adrenergic mechanisms in human hypertension and in spontaneously hypertensive rats
E D Frohlich, M A Pfeffer
Archives of Internal Medicine
|
June 1, 1979
High blood pressure. A side effect of drugs, poisons, and food
F H Messerli, E D Frohlich
Page
of 37